Anbogen Therapeutics Announces Completion of A+ Round Financing to Advance ABT-301 Phase II Clinical Trial

Anbogen Therapeutics Taiwan Maryland United Kingdom

View original content:https://www.prnewswire.co.uk/news-releases/anbogen-therapeutics-announces-completion-of-a-round-financing-to-advance-abt-301-phase-ii-clinical-trial-302183998.html